Fig. 2From: The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)The decision tree model of the study. RA: Rheumatoid Arthritis; MTX: methotrexate; HCQ: hydroxychloroquine; SSZ: sulfasalazineBack to article page